Gordon B. Mills

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

46.7Author DataRank

Indexed papers

19in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 19 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The Cancer Genome Atlas Pan-Cancer analysis project

Nature Genetics(2013)10.1038/ng.2764

Top 1%

13.2DataRank

Top 1%9611 citations

John N. Weinstein, Eric A. Collisson, Gordon B. Mills, Kenna R. Mills Shaw, Brad A Ozenberger +7 more

Papers

Driven by 132 papers — median percentile 28. Top paper: “The Cancer Genome Atlas Pan-Cancer analysis project”.

The Cancer Genome Atlas Pan-Cancer analysis project

Nature Genetics(2013)10.1038/ng.2764

Top 1%

13.2DataRank

Top 1%9611 citations

John N. Weinstein, Eric A. Collisson, Gordon B. Mills, Kenna R. Mills Shaw, Brad A Ozenberger +7 more

An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics

Cell(2018)10.1016/j.cell.2018.02.052

Top 2%

8.1DataRank

Top 2%3980 citations

Katherine A. Hoadley, Laila M. Poisson, Alexander J. Lazar, Andrew D. Cherniack, Albert J. Kovatich +866 more

Next-generation characterization of the Cancer Cell Line Encyclopedia

Nature(2019)10.1038/s41586-019-1186-3

Top 3%

6.8DataRank

Top 3%3735 citations

Franklin W. Huang, Gregory V. Kryukov, E. Robert McDonald, Jordi Barretina, Ellen T. Gelfand +68 more

Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics

Cell(2018)10.1016/j.cell.2018.03.033

Top 3%

6.4DataRank

Top 3%447 citations

Matthew H. Bailey, Hoifung Poon, Vesteinn Thorsson, Antonio Colaprico, Andreas Bender +883 more

Pan-cancer analysis of whole genomes

Nature(2020)10.1038/s41586-020-1969-6

Top 3%

5.9DataRank

Top 3%3307 citations

Lauri A. Aaltonen, Federico Abascal, Adam Abeshouse, Hiroyuki Aburatani, David J. Adams +1244 more

Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas

Cell Reports(2018)10.1016/j.celrep.2018.03.046

N/A

5.5DataRank · unranked

186 citations

Francisco Sanchez-Vega, Konnor C. La, Joshua Armenia, Walid K. Chatila, Augustin Luna +869 more

Analyses of non-coding somatic drivers in 2,658 cancer whole genomes

Nature(2020)10.1038/s41586-020-1965-x

Top 5%

4.6DataRank

Top 5%668 citations

Federico Abascal, Jeremiah A. Wala, Ofer Shapira, Grace Tiao, Henrik Hornshøj +1240 more

Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer

Breast Cancer Research(2020)10.1186/s13058-020-01354-y

N/A

3.0DataRank · unranked

148 citations

Cristina Saura, Romualdo Barroso‐Sousa, Hao Guo, Eva Ciruelos, Begoña Bermejo +18 more

Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer

Cell Reports(2020)10.1016/j.celrep.2020.03.066

N/A

2.9DataRank · unranked

143 citations

Li Zhao, Christine Rojas, Nicholas W. Bateman, Hui Yao, Olivia D. Lara +41 more

Inhibition of the ATM/Chk2 axis promotes cGAS/STING signaling in ARID1A-deficient tumors

Journal of Clinical Investigation(2020)10.1172/jci130445

N/A

2.9DataRank · unranked

107 citations

Lin Yang, Chen Wang, Zhao Wei, Zhenlin Ju, Wei Zhang +11 more

A multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugs

Nature Biotechnology(2022)10.1038/s41587-022-01379-y

N/A

1.4DataRank · unranked

47 citations

Dylan C. Blumberg, James E. Korkola, Laura M. Heiser, John Muschler, Pepper Schedin +6 more

Oncogenic Signaling Pathways in The Cancer Genome Atlas

Cell(2018)10.1016/j.cell.2018.03.035

N/A

1.2DataRank · unranked

3322 citations

Marco Mina, Joshua Armenia, Walid K. Chatila, Augustin Luna, Konnor C. La +891 more

The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers

Nature Medicine(2004)10.1038/nm1125

N/A

0.937DataRank · unranked

514 citations

John P Lahad, Wen-lin Kuo, Anna Lapuk, Kyosuke Yamada, Nelly Auersperg +10 more

Caveolin-1 and Sox-2 are predictive biomarkers of cetuximab response in head and neck cancer

JCI Insight(2021)10.1172/jci.insight.151982

N/A

0.791DataRank · unranked

19 citations

Rex H. Lee, Hua Li, Neil E. Bhola, Rachel A. O’Keefe, Mohammad Naser +16 more

Activity of dasatinib against L576P KIT mutant melanoma: Molecular, cellular, and clinical correlates

Molecular Cancer Therapeutics(2009)10.1158/1535-7163.mct-09-0459

N/A

0.777DataRank · unranked

177 citations

Jonathan C. Trent, Katherine Stemke-Hale, Alexander J. Lazar, Sabrina Pricl, Giovanni M. Pavan +11 more

Spatially interacting phosphorylation sites and mutations in cancer

Nature Communications(2021)10.1038/s41467-021-22481-w

N/A

0.745DataRank · unranked

27 citations

Daniel Cui Zhou, Liang-Bo Wang, Amila Weerasinghe, Abdülkadir Elmas, Ruiyang Liu +16 more

A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models

UNC Libraries(2020)10.17615/43yk-w772

Top 31%

0.649DataRank

Top 31%17 citations

Qing Lai, Pavel Zuloaga, Amber M. Froehlich, Edward S. Chen, Jian Huang +24 more

Targeting mTOR signaling overcomes acquired resistance to combined BRAF and MEK inhibition in BRAF-mutant melanoma

Oncogene(2021)10.1038/s41388-021-01911-5

N/A

0.624DataRank · unranked

63 citations

Wei Zhang, Gao Zhang, Lawrence N. Kwong, Hezhe Lu, Jiufeng Tan +17 more

Peritoneal Spread of Ovarian Cancer Harbors Therapeutic Vulnerabilities Regulated by FOXM1 and EGFR/ERBB2 Signaling

Cancer Research(2020)10.1158/0008-5472.can-19-3717

N/A

0.612DataRank · unranked

58 citations

Bindu Nair, Anjali Geethadevi, Jasmine George, Ajay Nair, Shirng‐Wern Tsaih +11 more

Large-scale Characterization of Drug Responses of Clinically Relevant Proteins in Cancer Cell Lines

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.07.03.186908

Top 34%

0.578DataRank

Top 34%10 citations

Jun Li, Mei‐Ju Chen, Zhenlin Ju, Nicole K. Nesser, Katie Johnson-Camacho +20 more

Costimulation of γδTCR and TLR7/8 promotes Vδ2 T-cell antitumor activity by modulating mTOR pathway and APC function

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-003339

N/A

0.524DataRank · unranked

32 citations

Hui Chen, Shujing Liu, Jie Zhang, Hezhe Lu, Rajasekharan Somasundaram +19 more

Genomic, Transcriptomic, and Proteomic Profiling of Metastatic Breast Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4048

N/A

0.510DataRank · unranked

29 citations

Xiaofeng Zheng, Christian X. Cruz Pico, Tae‐Beom Kim, Ken Chen, Anil Korkut +9 more

Interleukin enhancer‐binding factor 2 promotes cell proliferation and DNA damage response in metastatic melanoma

Clinical and Translational Medicine(2021)10.1002/ctm2.608

N/A

0.494DataRank · unranked

26 citations

Matías A. Bustos, Rebecca Groß, Romela Irene Ramos, Teh‐Ling Takeshima, Gordon B. Mills +3 more

Neural Crest-Like Stem Cell Transcriptome Analysis Identifies LPAR1 in Melanoma Progression and Therapy Resistance

Cancer Research(2021)10.1158/0008-5472.can-20-1496

N/A

0.489DataRank · unranked

25 citations

Vito W. Rebecca, Andrew V. Kossenkov, Thomas Connelly, Qin Liu, Alexis Gutierrez +43 more

RPPA SPACE: an R package for normalization and quantitation of Reverse-Phase Protein Array data

Bioinformatics(2022)10.1093/bioinformatics/btac665

N/A

0.464DataRank · unranked

21 citations

Shwetha V. Kumar, James Melott, Mary A. Rohrdanz, Chris Wakefield, Zhenlin Ju +7 more

A protein expression atlas on tissue samples and cell lines from cancer patients provides insights into tumor heterogeneity and dependencies

Nature Cancer(2024)10.1038/s43018-024-00817-x

N/A

0.449DataRank · unranked

19 citations

Wei Liu, Kamalika Mojumdar, Hong Kim, Zhicheng Zhou, Zhenlin Ju +9 more

Deciphering single-cell heterogeneity and cellular ecosystem dynamics during prostate cancer progression

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.12.18.629070

Top 44%

0.418DataRank

Top 44%10 citations

Jianming Zeng, Canping Chen, Xiaofan Zhao, Tingting Zhang, George Thomas +7 more

A phase II study of MK-2206, an AKT inhibitor, in uterine serous carcinoma

Gynecologic Oncology Reports(2022)10.1016/j.gore.2022.100974

N/A

0.416DataRank · unranked

15 citations

Niya Xiong, Andrea P. Myers, Nabihah Tayob, Victoria Engvold, Madeline Polak +14 more

Supervised learning of high-confidence phenotypic subpopulations from single-cell data

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.03.23.533712

N/A

0.324DataRank · unranked

6 citations

Canping Chen, Alexey V. Danilov, Susan Liu, Xiangnan Guan, Shunyi Du +9 more

Multi-omics analysis of serial samples from metastatic TNBC patients on PARP inhibitor monotherapy provide insight into rational PARP inhibitor therapy combinations

medRxiv(2020)10.1101/2020.07.25.20146431

N/A

0.208DataRank · unranked

3 citations

Allen Li, Allison Creason, Courtney B. Betts, Jamie M. Keck, Brett Johnson +23 more

Author Correction: Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis

Communications Biology(2022)10.1038/s42003-022-03769-z

N/A

0.165DataRank · unranked

2 citations

Lars Feuerbach, Chen Hong, David Mas-Ponte, Randi Istrup Pedersen, PCAWG Drivers and Functional Interpretation Group +1255 more

EFFORT: EFFicacy Of adavosertib in parp ResisTance: A randomized two-arm non-comparative phase II study of adavosertib with or without olaparib in women with PARP-resistant ovarian cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5505

N/A

0DataRank · unranked

83 citations

Robert L. Coleman, Bryan Fellman, Ying Yuan, Anil K. Sood, Pamela T. Soliman +15 more

Development of novel immunotherapy based on nanoparticle co-delivering PLK1 and PD-L1 inhibitors for lung cancer treatment

Research Square(2021)10.21203/rs.3.rs-142908/v1

N/A

0DataRank · unranked

2 citations

Worapol Ngamcherdtrakul, Natnaree Siriwon, Daniel S. Bejan, Sherif M. Reda, Ruijie Wang +8 more

Multiplex spatial systems analysis of local nanodose drug responses predicts effective treatment combinations of immunotherapies and targeted agents in mammary carcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.09.01.458631

N/A

0DataRank · unranked

2 citations

Dylan C. Blumberg, James E. Korkola, Laura M. Heiser, John Muschler, Pepper J. Schedin +6 more

Selective abrogation of S6K2 maps lipid homeostasis as a survival vulnerability in MAPKi-resistant NRAS MUT melanoma

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.04.07.438684

N/A

0DataRank · unranked

0 citations

Adam N. Guterres, Hsin‐Yi Chen, Delaine M. Zundell, Segundo Del Aguila, Patricia Reyes-Uribe +11 more

Systematic identification of synergistic combinations of targeted agents and immunotherapies in breast cancer using intratumor multiplex implantable microdevice assay

Research Square(2021)10.21203/rs.3.rs-1054728/v1

N/A

0DataRank · unranked

0 citations

Dylan C. Blumberg, James E. Korkola, Laura M. Heiser, John Muschler, Pepper Schedin +6 more

Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment

Nature Communications(2022)10.1038/s41467-022-31926-9

N/A

0DataRank · unranked

191 citations

Worapol Ngamcherdtrakul, Molly A. Nelson, Natnaree Siriwon, Ruijie Wang, Husam Y. Zaidan +10 more

HRS phosphorylation drives immunosuppressive exosome secretion and restricts CD8+ T-cell infiltration into tumors

Nature Communications(2022)10.1038/s41467-022-31713-6

N/A

0DataRank · unranked

84 citations

Bin Wu, Ting Li, Lynn A. Beer, Gaurav Sharma, Mingyue Li +23 more

[18F]FluorThanatrace ([18F]FTT) PET Imaging of PARP-Inhibitor Drug-Target Engagement as a Biomarker of Response in Ovarian Cancer, a Pilot Study

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1602

N/A

0DataRank · unranked

32 citations

Sarah B. Gitto, Mehran Makvandi, Hyoung Kim, Sergey Medvedv, Joanna K. Weeks +16 more

Biomolecular Condensation: A New Phase in Cancer Research

Cancer Discovery(2022)10.1158/2159-8290.cd-21-1605

N/A

0DataRank · unranked

21 citations

Daniel J. McGrail, Thomas M. Lozanoski, Brandon S. Dunn, David Shih, Kara M. Cirillo +7 more

L1CAM is required for early dissemination of fallopian tube carcinoma precursors to the ovary

Communications Biology(2022)10.1038/s42003-022-04314-8

N/A

0DataRank · unranked

19 citations

Rebecca Spivak, Hunter D. Reavis, Jagmohan Hooda, Yi Feng, Paul Kroeger +9 more

Adjuvant treatment in early-stage endometrial cancer: context-dependent impact of somatic CTNNB1 mutation on recurrence-free survival

International Journal of Gynecological Cancer(2022)10.1136/ijgc-2021-003340

N/A

0DataRank · unranked

12 citations

Bryan Fellman, Gordon B. Mills, Jessica L. Bowser, Su-Su Xie, Russell R. Broaddus +1 more

BET inhibition induces vulnerability to MCL1 targeting through upregulation of fatty acid synthesis pathway in breast cancer

Cell Reports(2022)10.1016/j.celrep.2022.111304

N/A

0DataRank · unranked

8 citations

Augustin Luna, Heping Wang, Behnaz Bozorgui, Xubin Li, Maga Sanchez +16 more

Identification of biomarkers of response to preoperative talazoparib monotherapy in treatment naïve gBRCA+ breast cancers

npj Breast Cancer(2022)10.1038/s41523-022-00427-9

N/A

0DataRank · unranked

11 citations

Zhongqi Ge, Fei Yang, Alejandro Contreras, Sanghoon Lee, Jason B. White +9 more

In vivofunctional characterization of EGFR variants identifies novel drivers of glioblastoma

Neuro-Oncology(2022)10.1093/neuonc/noac215

N/A

0DataRank · unranked

2 citations

Kathleen Kong, Brittney Lozzi, Estefania Luna-Figueroa, Alexis Cervantes, Rachel Naomi Curry +7 more

Ongoing Replication Stress Response and New Clonal T Cell Development Discriminate Between Liver and Lung Recurrence Sites and Patient Outcomes in Pancreatic Ductal Adenocarcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.05.04.490552

N/A

0DataRank · unranked

3 citations

Carl Pelz, Patrick J. Worth, Sydney Owen, Dove Keith, Ellen M. Langer +19 more

Development of novel immunotherapy based on nanoparticle co-delivering PLK1 and PD-L1 inhibitors for lung cancer treatment

Research Square(2022)10.21203/rs.3.rs-142908/v2

N/A

0DataRank · unranked

0 citations

Worapol Ngamcherdtrakul, Molly A. Nelson, Natnaree Siriwon, Ruijie Wang, Husam Y. Zaidan +10 more

Beyond BRCA: Discovery of novel causes and consequences of homologous recombination deficiencies

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.10.01.510467

N/A

0DataRank · unranked

0 citations

Yang Li, Roger S. Smith, Bin Feng, Hui Dai, Yongsheng Li +9 more

Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer

Research Square(2022)10.21203/rs.3.rs-2248209/v1

N/A

0DataRank · unranked

0 citations

Turçin Saridogan, Argun Akçakanat, Ming Zhao, Kurt W. Evans, Erkan Yuca +11 more

Stiff matrix induces exosome secretion to promote tumour growth

Nature Cell Biology(2023)10.1038/s41556-023-01092-1

N/A

0DataRank · unranked

229 citations

Di-Ao Liu, Lei Guan, Phyoe Kyawe Myint, LiKang Chin, Hien Dang +16 more

Upregulation of exosome secretion from tumor-associated macrophages plays a key role in the suppression of anti-tumor immunity

Cell Reports(2023)10.1016/j.celrep.2023.113224

N/A

0DataRank · unranked

78 citations

Youtao Lu, Xuexiang Han, Jingbo Yang, Zhiyuan Qin, Wei Zhang +20 more

MYC Deregulation and PTEN Loss Model Tumor and Stromal Heterogeneity of Aggressive Triple-Negative Breast Cancer

Nature Communications(2023)10.1038/s41467-023-40841-6

N/A

0DataRank · unranked

45 citations

Xiaoyan Wang, Nicholas L. Calistri, Jennifer Eng, Colin J. Daniel, Luke Ternes +24 more

Widespread BRCA1/2-independent homologous recombination defects are caused by alterations in RNA-binding proteins

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101255

N/A

0DataRank · unranked

18 citations

Yang Li, Roger S. Smith, Bin Feng, Hui Dai, Limei Hu +9 more

Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer

Scientific Reports(2023)10.1038/s41598-023-46586-y

N/A

0DataRank · unranked

15 citations

Argun Akçakanat, Ming Zhao, Kurt W. Evans, Erkan Yuca, Stephen Scott +11 more

Accessible high-throughput single-cell whole-genome sequencing with paired chromatin accessibility

Cell Reports Methods(2023)10.1016/j.crmeth.2023.100625

N/A

0DataRank · unranked

9 citations

Travis W. Moore, Brendan L. O’Connell, Ruth V. Nichols, John Muschler, Dove Keith +6 more

Panobinostat Induced Spatial In Situ Biomarkers Predictive of Anti-PD-1 Efficacy in Mouse Mammary Carcinoma

Cells(2023)10.3390/cells12020308

N/A

0DataRank · unranked

5 citations

Dylan C. Blumberg, AeSoon Bensen, Gordon B. Mills, Oliver Jonas, Zuzana Tatárová

Multiplatform Analysis of Intratumoral PTEN Heterogeneity in Melanoma

Journal of Investigative Dermatology(2023)10.1016/j.jid.2023.01.034

N/A

0DataRank · unranked

4 citations

Mariana Petaccia de Macêdo, Fernando C. L. Carapeto, Feng Wang, Diego M. Marzese, Khalida Wani +12 more

Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancer

Research Square(2023)10.21203/rs.3.rs-3314138/v1

N/A

0DataRank · unranked

2 citations

Yasuto Kinose, Haineng Xu, Hyoung Kim, Sushil Kumar, Xiaoyin Shan +19 more

Longitudinal and multimodal auditing of tumor adaptation to CDK4/6 inhibitors in HR+ metastatic breast cancers

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.09.27.557464

N/A

0DataRank · unranked

1 citations

Julian Egger, Cameron Watson, Shamilene Sivagnanam, Koei Chin, Kevin Hawthorne +18 more

Data from Cancer Stem Cells Contribute to Cisplatin Resistance in Brca1/p53–Mediated Mouse Mammary Tumors

(2023)10.1158/0008-5472.c.6497703

N/A

0DataRank · unranked

0 citations

Christopher R. Smith, Shuanzeng Wei, Yoon Kim, Gordon B. Mills, Gabriel N. Hortobágyi +3 more

Supplemental Figure 3 from Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics

Figshare(2023)10.1158/0008-5472.22378737.v1

Top 100%

0DataRank

Top 100%0 citations

Ana-Maria Gonzalez-Angulo, Katherine Stemke‐Hale, Michael Z. Gilcrease, Savitri Krishnamurthy, Ju‐Seog Lee +22 more

Data from 3-Phosphoinositide–Dependent Kinase 1 Potentiates Upstream Lesions on the Phosphatidylinositol 3-Kinase Pathway in Breast Carcinoma

(2023)10.1158/0008-5472.c.6499247.v1

N/A

0DataRank · unranked

0 citations

Tao Su, Lao H. Saal, Susan Koujak, Benjamin D. Hopkins, Christina R. Barkley +24 more

Data from A Kinome-Wide Screen Identifies the Insulin/IGF-I Receptor Pathway as a Mechanism of Escape from Hormone Dependence in Breast Cancer

(2023)10.1158/0008-5472.c.6503028.v1

N/A

0DataRank · unranked

0 citations

Todd W. Miller, Justin M. Balko, María G. Kuba, Violeta Sánchez, R. Adam Smith +9 more

Data from An Integrative Genomic and Proteomic Analysis of PIK3CA, PTEN, and AKT Mutations in Breast Cancer

(2023)10.1158/0008-5472.c.6497325

Top 100%

0DataRank

Top 100%0 citations

Ana M. González-Angulo, Aňa Lluch, Richard M. Neve, Wen-lin Kuo, Michael A. Davies +17 more

Data from MEK Inhibition Remodels the Immune Landscape of Mutant KRAS Tumors to Overcome Resistance to PARP and Immune Checkpoint Inhibitors

(2023)10.1158/0008-5472.c.6512709.v1

N/A

0DataRank · unranked

0 citations

Xi Li, Yu Fu, Ensong Guo, Youqiong Ye, Fuxia Li +12 more

Data from Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer

(2023)10.1158/0008-5472.c.6513646.v1

Top 100%

0DataRank

Top 100%0 citations

Yongsheng Li, Sairahul R. Pentaparthi, Daniel J. McGrail, Raymond Zou, Li Guo +22 more

Supplementary Table 4 from Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics

(2023)10.1158/0008-5472.22378674

Top 100%

0DataRank

Top 100%0 citations

Ana-Maria Gonzalez-Angulo, Katherine Stemke‐Hale, Michael Z. Gilcrease, Savitri Krishnamurthy, Ju‐Seog Lee +22 more

Data from Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer

(2023)10.1158/0008-5472.c.6513646

Top 100%

0DataRank

Top 100%0 citations

Yongsheng Li, Sairahul R. Pentaparthi, Daniel J. McGrail, Raymond Zou, Li Guo +22 more

Data from Integrated Genomic Characterization of the Human Immunome in Cancer

(2023)10.1158/0008-5472.c.6512134.v1

N/A

0DataRank · unranked

0 citations

Brandon Burgman, Daniel J. McGrail, Ming Sun, Dan Qi, Sachet A. Shukla +10 more

Data from Peritoneal Spread of Ovarian Cancer Harbors Therapeutic Vulnerabilities Regulated by FOXM1 and EGFR/ERBB2 Signaling

(2023)10.1158/0008-5472.c.6511900.v1

N/A

0DataRank · unranked

0 citations

Bindu Nair, Anjali Geethadevi, Jasmine George, Ajay Nair, Shirng‐Wern Tsaih +11 more

Supplementary Materials and Methods from PIK3CA/PTEN Mutations and Akt Activation As Markers of Sensitivity to Allosteric mTOR Inhibitors

Figshare(2023)10.1158/1078-0432.22446608.v1

Top 100%

0DataRank

Top 100%0 citations

Argun Akçakanat, Huiqin Chen, Kim‐Anh Do, Takafumi Sangai, Farrell Adkins +10 more

Data from Phosphorylated 4E-BP1 Is Associated with Poor Survival in Melanoma

(2023)10.1158/1078-0432.c.6517965

N/A

0DataRank · unranked

0 citations

Melanie Warycha, Michael A. Davies, Vanessa Rodrik-Outmezguine, Xi Kathy Zhou, Herman Yee +7 more

Data from Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal Cancer

(2023)10.1158/1078-0432.c.6530433

N/A

0DataRank · unranked

0 citations

Yucai Wang, Muddassir Syed, Alexey V. Sorokin, Oluwadara Coker, Joanne Xiu +17 more

Data from Targeting Extracellular Matrix Remodeling Restores BRAF Inhibitor Sensitivity in BRAFi-resistant Melanoma

(2023)10.1158/1078-0432.c.6529614

N/A

0DataRank · unranked

0 citations

Varsha Thakur, Yuan Li, Juliano T. Freitas, Patrick M. Zmina, Vijay S. Thakur +16 more

Data from Activity of dasatinib against L576P KIT mutant melanoma: Molecular, cellular, and clinical correlates

(2023)10.1158/1535-7163.c.6531608

N/A

0DataRank · unranked

0 citations

Jonathan C. Trent, Katherine Stemke‐Hale, Alexander J. Lazar, Sabrina Pricl, Giovanni M. Pavan +11 more

Data from Phosphorylated 4E-BP1 Is Associated with Poor Survival in Melanoma

(2023)10.1158/1078-0432.c.6517965.v1

N/A

0DataRank · unranked

0 citations

Melanie Warycha, Michael A. Davies, Vanessa Rodrik-Outmezguine, Xi Kathy Zhou, Herman Yee +7 more

Data from Targeting Extracellular Matrix Remodeling Restores BRAF Inhibitor Sensitivity in BRAFi-resistant Melanoma

(2023)10.1158/1078-0432.c.6529614.v1

N/A

0DataRank · unranked

0 citations

Varsha Thakur, Yuan Li, Juliano T. Freitas, Patrick M. Zmina, Vijay S. Thakur +16 more

Data from Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal Cancer

(2023)10.1158/1078-0432.c.6530433.v1

N/A

0DataRank · unranked

0 citations

Yucai Wang, Muddassir Syed, Alexey V. Sorokin, Oluwadara Coker, Joanne Xiu +17 more

Data from Activity of dasatinib against L576P KIT mutant melanoma: Molecular, cellular, and clinical correlates

(2023)10.1158/1535-7163.c.6531608.v1

N/A

0DataRank · unranked

0 citations

Jonathan C. Trent, Katherine Stemke‐Hale, Alexander J. Lazar, Sabrina Pricl, Giovanni M. Pavan +11 more

Data from A Modified Nucleoside 6-Thio-2′-Deoxyguanosine Exhibits Antitumor Activity in Gliomas

(2023)10.1158/1078-0432.c.6531102.v1

N/A

0DataRank · unranked

0 citations

Shiyou Wei, Milan R. Savani, Xiang Lin, Kuang Du, Ilgen Mender +33 more

Data from Genomic, Transcriptomic, and Proteomic Profiling of Metastatic Breast Cancer

(2023)10.1158/1078-0432.c.6530036

Top 100%

0DataRank

Top 100%0 citations

Xiaofeng Zheng, Christian X. Cruz Pico, Tae‐Beom Kim, Ken Chen, Anil Korkut +9 more

Supplementary Materials and Methods from PIK3CA/PTEN Mutations and Akt Activation As Markers of Sensitivity to Allosteric mTOR Inhibitors

(2023)10.1158/1078-0432.22446608

Top 100%

0DataRank

Top 100%0 citations

Argun Akçakanat, Huiqin Chen, Kim‐Anh Do, Takafumi Sangai, Farrell Adkins +10 more

Data from Dual Inhibition of Tumor Energy Pathway by 2-Deoxyglucose and Metformin Is Effective against a Broad Spectrum of Preclinical Cancer Models

(2023)10.1158/1535-7163.c.6535354

N/A

0DataRank · unranked

0 citations

Eun Sung Park, Jiyong Liang, Jennifer B. Dennison, Dimitra Tsavachidou, Catherine Nguyen-Charles +11 more

Systematic Pan-cancer Functional Inference and Validation of Hyper, Hypo and Neomorphic Mutations

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.04.29.538640

N/A

0DataRank · unranked

0 citations

Samuel C. S. Tsang, Gordon B. Mills, Andrea Califano, Somnath Tagore

The polymeric fluoropyrimidine CF10 overcomes limitations of 5-FU in pancreatic ductal adenocarcinoma cells through increased replication stress

Cancer Biology & Therapy(2024)10.1080/15384047.2024.2421584

N/A

0DataRank · unranked

10 citations

Roberto Di Niro, Soon Young Park, Kang Jin Jeong, Madeline D. Hedberg, Alexander Smith +8 more

Ancestral Differences in Anticancer Treatment Efficacy and Their Underlying Genomic and Molecular Alterations

Cancer Discovery(2024)10.1158/2159-8290.cd-24-0827

N/A

0DataRank · unranked

10 citations

Jingwen Yang, Alejandro A. Schäffer, Chengxuan Chen, Yuan Liu, Yamei Chen +9 more

Circulating Neoplastic-Immune Hybrid Cells Are Biomarkers of Occult Metastasis and Treatment Response in Pancreatic Cancer

Cancers(2024)10.3390/cancers16213650

N/A

0DataRank · unranked

5 citations

Michael Parappilly, Hannah C. Farley, Emile Latour, Lei Wang, Ashvin M. Nair +13 more

Androgen receptor activity inversely correlates with immune cell infiltration and immunotherapy response across multiple cancer lineages

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.05.08.593181

N/A

0DataRank · unranked

7 citations

Faming Zhao, Julie N. Graff, Canping Chen, Xiyue Zhao, George Thomas +7 more

Targeted Dynamic Phospho-Proteogenomic Analysis of Gastric Cancer Cells Suggests Host Immunity Provides Survival Benefit

Molecular & Cellular Proteomics(2024)10.1016/j.mcpro.2024.100870

N/A

0DataRank · unranked

0 citations

Midori Iida, Takeshi Iwaya, Akiko Yashima‐Abo, Yuka Koizumi, Akari Endo +16 more

Ongoing replication stress tolerance and clonal T cell responses distinguish liver and lung recurrence and outcomes in pancreatic cancer

Nature Cancer(2025)10.1038/s43018-024-00881-3

N/A

0DataRank · unranked

33 citations

Jennifer Eng, Carl Pelz, Kevin Hawthorne, Patrick J. Worth, Shamilene Sivagnanam +33 more

Cell free RNA detection of pancreatic cancer in pre diagnostic high risk and symptomatic patients

Nature Communications(2025)10.1038/s41467-025-62685-y

N/A

0DataRank · unranked

8 citations

Elias Spiliotopoulos, Rowan Callahan, C. Ward Kirschbaum, C. Bailey, Hyun Ji Kim +10 more

The role of long non‐coding RNAs in lung cancer metastasis: Molecular mechanisms, pathogenesis and clinical implications

Clinical and Translational Medicine(2025)10.1002/ctm2.70429

N/A

0DataRank · unranked

8 citations

Gordon B. Mills, Christopher I. Amos, Musaffe Tuna

Single-cell RNA sequencing reveals different cellular states in malignant cells and the tumor microenvironment in primary and metastatic ER-positive breast cancer

npj Breast Cancer(2025)10.1038/s41523-025-00808-w

N/A

0DataRank · unranked

8 citations

Tugba Y. Ozmen, Aysegul Ors, Mahnaz Janghorban, Matthew J. Rames, Xi Li +5 more

OmicsTweezer: A distribution-independent cell deconvolution model for multi-omics Data

Cell Genomics(2025)10.1016/j.xgen.2025.100950

N/A

0DataRank · unranked

7 citations

Faming Zhao, Tao Ren, Canping Chen, Katelyn T. Byrne, Alexey V. Danilov +6 more

Selective abrogation of S6K2 identifies lipid homeostasis as a survival vulnerability in MAPK inhibitor–resistant NRAS -mutant melanoma

Science Translational Medicine(2025)10.1126/scitranslmed.adp8913

N/A

0DataRank · unranked

6 citations

Adam N. Guterres, Hsin-Yi Chen, Delaine M. Zundell, Segundo W Del Aguila, Patricia Reyes-Uribe +12 more

CD8+ T cells in the tumor microenvironment modulate the response to endocrine therapy in breast cancer

Journal of Clinical Investigation(2025)10.1172/jci188458

N/A

0DataRank · unranked

4 citations

Yunguan Wang, Dhivya R. Sudhan, Paula I. González-Ericsson, Luigi Formisano, Nisha Unni +26 more

Toward universal immunofluorescence normalization for multiplex tissue imaging with UniFORM

Cell Reports Methods(2025)10.1016/j.crmeth.2025.101172

N/A

0DataRank · unranked

3 citations

Kaoutar Ait-Ahmad, Sam Kupp, Zachary Sims, Eric Cramer, Zeynep Sayar +6 more

Elevated Tumor-Associated Androgen Receptor Activity Correlates with Poor Immune Infiltration and Immunotherapy Response across Cancer Types

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0409

N/A

0DataRank · unranked

2 citations

Faming Zhao, Julie N. Graff, Canping Chen, Yi Zhang, Jayne M. Stommel +11 more

Utilizing cohort-level and individual networks to predict best response in patients with metastatic triple negative breast cancer

npj Precision Oncology(2025)10.1038/s41698-025-00959-w

N/A

0DataRank · unranked

0 citations

Christina Zheng, Allison Creason, Zahi Mitri, Gordon B. Mills, Shannon K. McWeeney +1 more

Tumor-intrinsic MHC-II activation in pancreatic ductal adenocarcinoma enhances immune response and treatment efficacy

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.10.21.683745

N/A

0DataRank · unranked

0 citations

Kyle P. Gribbin, Xi Li, Tugba Y. Ozmen, Furkan Ozmen, Shamilene Sivagnanam +15 more

Patient-derived xenograft models of Fanconi anemia–associated head and neck cancer identify personalized therapeutic strategies

Journal of Clinical Investigation(2025)10.1172/jci195334

N/A

0DataRank · unranked

0 citations

Hua Li, Benjamin A Harrison, Andrew Webster, Joanna Pucilowska, Austin Nguyen +21 more

Transcriptional and phenotypic heterogeneity underpinning venetoclax resistance in AML

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.01.27.577579

N/A

0DataRank · unranked

10 citations

Natalia Baran, Yuefan Huang, Cassandra L. Ramage, Laurie Cooper, Shan He +7 more

Author Correction: Combined burden and functional impact tests for cancer driver discovery using DriverPower

Nature Communications(2022)10.1038/s41467-022-32343-8

N/A

0DataRank · unranked

0 citations

PCAWG Drivers and Functional Interpretation Working Group, Federico Abascal, Samirkumar B. Amin, Pratiti Bandopadhayay, Rameen Beroukhim +1242 more

Spatially Interacting Phosphorylation Sites and Mutations in Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.02.14.431184

N/A

0DataRank · unranked

0 citations

Daniel Cui Zhou, Liang-Bo Wang, Amila Weerasinghe, Ruiyang Liu, Yige Wu +16 more

Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models

Nature Communications(2020)10.1038/s41467-020-17127-2

N/A

0DataRank · unranked

372 citations

Haineng Xu, Erin George, Dorothy Hallberg, Sushil Kumar, Veena Jagannathan +16 more

Verteporfin Inhibits PD-L1 through Autophagy and the STAT1–IRF1–TRIM28 Signaling Axis, Exerting Antitumor Efficacy

Cancer Immunology Research(2020)10.1158/2326-6066.cir-19-0159

N/A

0DataRank · unranked

107 citations

Lulu Wang, Chao Wang, Jianfeng Shen, Bojin Su, Anantha Marisetty +24 more

Analysis of Ugandan cervical carcinomas identifies human papillomavirus clade–specific epigenome and transcriptome landscapes

Nature Genetics(2020)10.1038/s41588-020-0673-7

N/A

0DataRank · unranked

79 citations

Vanessa Porter, Zusheng Zong, Reanne Bowlby, Emma Titmuss, Constance Namirembe +27 more

Comprehensive assessment of computational algorithms in predicting cancer driver mutations

Genome biology(2020)10.1186/s13059-020-01954-z

N/A

0DataRank · unranked

63 citations

Jun Li, Yumeng Wang, Patrick Kwok‐Shing Ng, Yiu Huen Tsang, Kenna Shaw +3 more

Targeting Extracellular Matrix Remodeling Restores BRAF Inhibitor Sensitivity in BRAFi-resistant Melanoma

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-2773

N/A

0DataRank · unranked

45 citations

Varsha Thakur, Yuan Li, Juliano T. Freitas, Patrick M. Zmina, Vijay S. Thakur +16 more

Integrated Genomic Characterization of the Human Immunome in Cancer

Cancer Research(2020)10.1158/0008-5472.can-20-0384

N/A

0DataRank · unranked

32 citations

Brandon Burgman, Daniel J. McGrail, Ming Sun, Dan Qi, Sachet A. Shukla +10 more

Results of an abbreviated phase II study of AKT inhibitor MK-2206 in the treatment of recurrent platinum-resistant high grade serous ovarian, fallopian tube, or primary peritoneal carcinoma (NCT 01283035)

Gynecologic Oncology Reports(2020)10.1016/j.gore.2020.100546

N/A

0DataRank · unranked

18 citations

Zhenying Tan‐Wasielewski, Carol Aghajanian, Robert L. Coleman, Jennifer Curtis, Michelle S. Hirsch +6 more

Genetic Alterations in the PI3K/AKT Pathway and Baseline AKT Activity Define AKT Inhibitor Sensitivity in Breast Cancer Patient-derived Xenografts

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3324

N/A

0DataRank · unranked

41 citations

Marta Palafox, Laia Monserrat, Fara Brasó‐Maristany, Andreu Òdena, Mònica Sánchez-Guixé +26 more

Downregulation of the Ubiquitin-E3 Ligase RNF123 Promotes Upregulation of the NF-κB1 Target SerpinE1 in Aggressive Glioblastoma Tumors

Cancers(2020)10.3390/cancers12051081

N/A

0DataRank · unranked

30 citations

Matías A. Bustos, Xiaoqing Zhang, Romela Irene Ramos, Cong Tan, Yuuki Iida +11 more

Differential expression of MAGEA6 toggles autophagy to promote pancreatic cancer progression

eLife(2020)10.7554/elife.48963

N/A

0DataRank · unranked

29 citations

Yumeng Wang, Kathleen Kong, Caitlin L. Grzeskowiak, Oksana Zagorodna, Turgut Dogruluk +9 more

Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH -Mutant Molecular Profiles

UNC Libraries(2020)10.17615/7ms0-1a34

N/A

0DataRank · unranked

0 citations

Umadevi Veluvolu, Mario Berríos, David E. Kleiner, Donghui Tan, Johanna Gardner +95 more

Inferring causal molecular networks: empirical assessment through a community-based effort

UNC Libraries(2020)10.17615/j5nb-5n89

N/A

0DataRank · unranked

0 citations

Steven M. Hill, Daoud Meerzaman, Venkateshan Kannan, Bahman Afsari, Takeshi Hase +95 more

Comprehensive molecular characterization of gastric adenocarcinoma

DSpace@MIT (Massachusetts Institute of Technology)(2020)10.17615/eyft-ty56

N/A

0DataRank · unranked

0 citations

Amaro Taylor‐Weiner, Andy Chu, Carrie Sougnez, Nils Weinhold, Sheila M. Reynolds +27 more

Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer

UNC Libraries(2020)10.17615/s3ab-0w32

N/A

0DataRank · unranked

0 citations

Gordon B. Mills, Nilsa C. Ramirez, Andrew J. Mungall, Hailei Zhang, Nikolaus Schultz +95 more

A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma

UNC Libraries(2020)10.17615/a8zp-dq08

Top 100%

0DataRank

Top 100%0 citations

Andrew E. Aplin, Yiling Lu, Sébastien Jeay, Carol L. Shields, Michal Barzily-Rokni +49 more

Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics

UNC Libraries(2020)10.17615/twk7-x350

N/A

0DataRank · unranked

0 citations

Victor Weigman, Nicholas J. Wang, Vicente Valero, Aňa Lluch, Jane Fridlyand +22 more

Modulation of Breast Cancer Risk Biomarkers by High-Dose Omega-3 Fatty Acids: Phase II Pilot Study in Postmenopausal Women

UNC Libraries(2020)10.17615/q0z1-ym69

N/A

0DataRank · unranked

0 citations

Debra K. Sullivan, Brian K. Petroff, Brandon H. Hidaka, Carol J. Fabian, Carola M. Zalles +11 more

CCNE1 copy number is a biomarker for response to combination WEE1-ATR inhibition in ovarian and endometrial cancer models

Cell Reports Medicine(2021)10.1016/j.xcrm.2021.100394

N/A

0DataRank · unranked

91 citations

Erin George, Yasuto Kinose, Hyoung Kim, Jennifer Shah, Jasmine D. Peake +16 more

Relevance of circulating hybrid cells as a non-invasive biomarker for myriad solid tumors

Scientific Reports(2021)10.1038/s41598-021-93053-7

N/A

0DataRank · unranked

79 citations

Thomas L. Sutton, Brett S. Walker, Charles E. Gast, Luai Zarour, Sidharth K. Sengupta +29 more

WEE1 inhibition induces anti-tumor immunity by activating ERV and the dsRNA pathway

The Journal of Experimental Medicine(2021)10.1084/jem.20210789

N/A

0DataRank · unranked

72 citations

Rourou Xiao, Yifan Wu, Funian Lu, Chen Liu, Bin Yang +16 more

Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma

Journal of Clinical Investigation(2021)10.1172/jci150335

N/A

0DataRank · unranked

60 citations

Bhumsuk Keam, Janice Cho, Michelle J. Lee, Hye Ryun Kim, Hayarpi Torosyan +16 more

MEK Inhibition Remodels the Immune Landscape of Mutant KRAS Tumors to Overcome Resistance to PARP and Immune Checkpoint Inhibitors

Cancer Research(2021)10.1158/0008-5472.can-20-2370

N/A

0DataRank · unranked

55 citations

Xi Li, Yu Fu, Ensong Guo, Youqiong Ye, Fuxia Li +12 more

Multiomics analysis of serial PARP inhibitor treated metastatic TNBC inform on rational combination therapies

npj Precision Oncology(2021)10.1038/s41698-021-00232-w

N/A

0DataRank · unranked

27 citations

Allen Li, Allison Creason, Courtney B. Betts, Jamie M. Keck, Brett Johnson +23 more

Clinical and Functional Characterization of Atypical KRAS / NRAS Mutations in Metastatic Colorectal Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0180

N/A

0DataRank · unranked

39 citations

Yucai Wang, Muddassir Syed, Alexey V. Sorokin, Oluwadara Coker, Joanne Xiu +17 more

Expression of chimeric antigen receptor therapy targets detected by single-cell sequencing of normal cells may contribute to off-tumor toxicity

Cancer Cell(2021)10.1016/j.ccell.2021.09.016

N/A

0DataRank · unranked

36 citations

Yuan Liu, Qiang Li, Youqiong Ye, Lixia Diao, Yun Huang +5 more

A Modified Nucleoside 6-Thio-2′-Deoxyguanosine Exhibits Antitumor Activity in Gliomas

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0374

N/A

0DataRank · unranked

30 citations

Shiyou Wei, Milan R. Savani, Xiang Lin, Kuang Du, Ilgen Mender +33 more

mi-IsoNet: systems-scale microRNA landscape reveals rampant isoform-mediated gain of target interaction diversity and signaling specificity

Briefings in Bioinformatics(2021)10.1093/bib/bbab091

N/A

0DataRank · unranked

12 citations

Yongsheng Li, Kara M. Cirillo, Robert A. Marick, Zhe Su, Xing Yin +5 more

Uncoupling of gene expression from copy number presents therapeutic opportunities in aneuploid cancers

Cell Reports Medicine(2021)10.1016/j.xcrm.2021.100349

N/A

0DataRank · unranked

12 citations

Fang Wang, Gordon B. Mills, Ken Chen, Vakul Mohanty

Gordon B. Mills

Indexed papers

Top data-sharing exemplar

Papers